로딩 중…
지수 로딩 중…
AnaptysBio, Inc.
ANAB· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$57.51+1.30%
2026-06-18
Price Chart
AnaptysBio, Inc.+145.87%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.67B |
| Revenue | $232M |
| Net Income | $-27M |
| Total Assets | $330M |
| Net Assets | $13M |
| Value | |
| P/B | 131.29x |
| P/S | 7.20x |
| EV/EBITDA | 31.92x |
| FCF Yield | 0.26% |
| Profitability | |
| ROA | -8.13% |
| Op. Margin | 17.56% |
| Revenue Growth | -7.98% |
| Financial Health | |
| Debt Ratio | 2486.37% |
| Total Debt | $277M |
| FCF | $4M |
| Cash | $248M |
| Current Ratio | 7.58x |
| Net Debt/EBITDA | 0.54x |
| Performance | |
| 1Y Return | 145.87% |
| 1M Return | -3.78% |
| From 52W High | -21.54% |
| 1Y MDD | -36.50% |
| Trading | |
| Volume | 608,831 shares |
| Trading Value | $35M |
| Per Share | |
| EPS | $-0.48 |
| BPS | $1.34 |